CTIBiotech

Featured

Next-Gen Drug Testing: Scientists Bioprint Long-Term Colon Cancer Models

Imagine a world where we can mimic the way cancer grows and evolves in the human body without actually relying on human trials. Building on this vision, scientists from CTIBiotech…

Featured

2022 Predictions: Bioprinting Leaders Weigh in

As 2021 comes to a close, the bioprinting field has a lot of reasons to be optimistic about the future. The bioprinting landscape has evolved rapidly in the last decade,…

CTI Biotech Unveils Two 3D Printed Skin Models for Commercialization

Cell therapy research startup CTIBiotech has unveiled two bioprinted full skin model technologies for skincare applications. Focused on providing researchers with the best tools to make the most human-compatible products,…

Interview: CTIBiotech’s 3D Microtumors Can Aid in the Fight Against Cancer

Understanding cancer cells is a fundamental part of looking for ways to cure the disease, which has been around for a long time. Cancer is the second leading cause of…

BASF and CTIBiotech Develop 3D Bioprinted Human Reconstructed Skin

3D reconstructed skin and epidermal models are a valuable tool in pharmaceutical and cosmetics testing, as well as for in vitro studies. 3D printing has shifted the paradigm in studies…

BASF & CTIBiotech: Bioprinting Expands to the Sebaceous Glands

If you are starting to get the impression that there is little researchers and innovators cannot do with 3D printing, you are thinking in the right direction—as are so many…